Quoi de NeuF

Get all the news on neurofibromatosis every month! Here is the March 2021 issue

Quoi de NeuF – March 2021 (French only)

Download PDF

Here’s what’s in store for you this month in Quoi de NeuF:

  • New clinical trial by Lyli, for atypical neurofibromatoses linked to NF1: Abemaciclib, the CDK4/6 inhibitor
  • NFs go global: 1st NF Latin America conference
  • The effect of turmeric and the Mediterranean diet on NF1 patients
  • February 22-29: Rare Disease Week